skip to Main Content

JUMP TO:  Must-Watch Videos · Variants · COVID-19 Vaccines · Masks ·
COVID-19 Prevention & Treatment Protocols · Ivermectin-How to Get It ·
Ivermectin-Evidence

Critical Information

Must-Watch Videos

bitchute.com/video/dG9Uq0X2ZpM6/
Health Freedom Louisiana invited Dr. Peter McCullough to discuss the importance of early intervention and treatment for COVID-19 with members of the Louisiana Legislature. Dr. Peter McCullough, an internationally renowned cardiologist and internist, is Vice Chief of Medicine at Baylor University Medical Center in Dallas, Texas as well as a Professor of Medicine and editor of two major medical journals. He has been successfully treating patients with COVID-19 for more than a year and has testified before Congress on the matter.

bitchute.com/video/aKu004vAQ531/
Health Freedom Louisiana invited Dr Robert Malone, the inventor of the mRNA technology that is utilized in the COVID-19 vaccines, to address the Louisiana Legislature and answer relevant questions regarding the COVID-19 vaccines.

The Highwire News and Talk Show – new episodes every Thursday, streaming live from their website

Variants

Geert Vanden Bossche is a virologist and a prominent vaccine developer who spoke in front of the World Health Organization months ago trying to sound the alarm but they didn’t listen and his predictions are coming true. Since then he has been writing articles and giving interviews trying to warn everyone of the danger of mass vaccination causing more virulent variants. ⁣⁣

Geert has held senior positions and has worked for various vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals); the Bill & Melinda Gates Foundation’s Global Health Discovery team as Senior Program Officer; the Global Alliance for Vaccines and Immunization (GAVI) as Senior Ebola Program Manager; and the German Center for Infection Research as Head of the Vaccine Development Office. ⁣

Noteworthy Posts by Geert Vanden Bossche

Mass Vaccination is Causing Variants

Last Word of Caution

Noteworthy Webinars/Interviews with Geert Vanden Bossche

Interview on The Highwire News Show

Emerging Infectious Variants Explained (Excerpt from Webinar)

Webinar with Dr. Peter McCullough

Interview: Mass Vaccination in a Pandemic

Evidence – Emerging Reports

Internal CDC Document Reveals Vaccinated People Can Transmit the Virus as Easily as Unvaccinated and Have as Much Viral Load as Unvaccinated

Newsweek – Lambda COVID Variant Shows Vaccine Resistance

Resources

COVID-19 Vaccines

Flyer: COVID-19 Vaccine Facts

Flyer: Abridged COVID-19 Vaccine Facts with Treatment Protocol Info

Memo on COVID-19 Vaccine Mandates by Liberty Counsel, a national nonprofit litigation, education and public policy organization advancing religious freedom, the sanctity of human life, and family.

Religious Exemption to COVID-19 vaccines and mask wearing for students, sample provided by First Liberty Institute

Philosophical Exemption to COVID-19 vaccines and mask wearing for students, sample provided by First Liberty Institute

Masks

Petition to END MASK MANDATES in Louisiana Schools & Universities

Medical Exemption to Masks for Students

According to Governor Edwards' Proclamation Number 137, on page 3, several exceptions exist to the face covering requirement including "any individual with a medical condition that prevents the wearing of a face covering.” Section E of Proclamation Number 137 states “Operators of businesses and organizations are entitled to rely on the representation of their customers, patrons, and employees regarding whether or not they qualify for an exception from the face covering requirements.” 

In other words, the Superintendent of your school may take you at your word that your child has a medical condition constituting an exception to the governor’s face covering requirement. Parents, if the Superintendent of your school requires anything beyond what the governor is requiring, a doctor’s note for example, that is NOT in the governor’s order. 

So please, Parents, when you tell the school that your child will not be wearing a face mask to school because of a medical condition, understand that you ARE IN COMPLIANCE with the governor’s order. Every child has a need to breathe unhindered by a mask.

If your exemption is denied for any reason, get it in writing. Why? Watch this: https://fb.watch/7aR8o5ZCzj/

Mask Flyer to Parents with Notice to School Administration to Refuse Mask Mandates

Notice for Employers, Universities and Other Institutions Mandating COVID-19 Masks, written by Children’s Health Defense

Religious Exemption to COVID-19 vaccines and mask wearing for students, sample provided by First Liberty Institute

Philosophical Exemption to COVID-19 vaccines and mask wearing for students, sample provided by First Liberty Institute

Mask Studies Packet

Are Face Masks Effective? The Evidence.

COVID-19 Prevention & Treatment Protocols

Natural treatments that work and are backed by science: jennifermargulis.net/natural-treatments-for-coronavirus/

This page has protocols for prevention, home treatment, early outpatient, hospital, and long-haul COVID-19: covid19criticalcare.com/covid-19-protocols/

Niacin (Vitamin B3) Protocol by Dmitry Kats, PhDniacincurescovid.com Follow him here: @nia3in

Dr. Zelenko prophylaxis (prevention) protocol: vladimirzelenkomd.com/zelenko-prophylaxis-protocol/

Dr. Zelenko treatment protocol: vladimirzelenkomd.com/zelenko-treatment-protocol/ 

Ivermectin – How to Get It

pushhealth.com/drugs/ivermectin

drsyedhaider.com/

covid19criticalcare.com/ivermectin-in-covid-19/how-to-get-ivermectin

Myfreedoctor.com

Speakwithanmd.com – We’ve received reports of appointments being cancelled (and money refunded) so this may not be a viable option.

Ivermectin – Evidence Supporting Its Use in Prevention & Treatment of COVID-19

Review of Emerging Evidence

Prophylactic Role of Ivermectin in Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Healthcare Workers – “Conclusion: Two doses (300 μg/kg/dose in a gap of 72 hours) of ivermectin chemoprophylaxis reduced COVID-19 infection by 83% among HCWs for one month.”

Why Is the FDA Attacking a Safe, Effective Drug?


References for COVID-19 Vaccine Facts Flyer currently being updated

  1. “Most locations probably have an infection fatality rate less than 0.20% and with ap- propriate, precise non-pharmacological measures that selectively try to protect high-risk vulnerable populations and settings, the infection fatality rate may be brought even lower.”
    who.int/bulletin/volumes/99/1/20-265892.pdf

  2. In Children, Risk of Covid-19 Death or Serious Illness Remains Extremely Low, New Studies Find

  3. Characteristics of Persons Who Died with COVID-19 — United States, February 12–May 18, 2020
    CDC: 94% of Covid-19 deaths had underlying medical conditions
    78% of COVID-19 patients hospitalized in the US overweight or obese, CDC finds

  4. Vitamin D Insufficiency May Account for Almost Nine of Ten COVID-19 Deaths: Time to Act. Comment on: “Vitamin D Deficiency and Outcome of COVID-19 Patients”. Nutrients 2020, 12, 2757

  5. Physicians across the country have been treating COVID-19 successfully for a year and a half.
    https://covid19criticalcare.com/videos-and-press/official-testimony/
    Peter McCullough, MD testifies to Texas Senate HHS Committee

  6. Study in American Journal of Therapeutics: Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines

    “Conclusions: Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease. The apparent safety and low cost suggest that ivermectin is likely to have a significant impact on the SARS-CoV-2 pandemic globally.”

  7. As we explain on the Exemptions page of our website, under Louisiana law R.S. 17:170 Louisiana has exemptions to daycare/school vaccination requirements:
    “E. No person seeking to enter any school or facility enumerated in Subsection A of this Section shall be required to comply with the provisions of this Section if the student or his parent or guardian submits either a written statement from a physician stating that the procedure is contraindicated for medical reasons, or a written dissent from the student or his parent or guardian is presented.”

    Further, while the COVID-19 vaccines are under EUA (Emergency Use Authorization), federal law 21 US Code 360bbb-3 states the “Required Conditions [for emergency use of a product]… include the following:
    (ii) Appropriate conditions designed to ensure that individuals to whom the product is administered are informed-
    (I) that the Secretary has authorized the emergency use of the product;
    (II) of the significant known and potential benefits and risks of such use, and of the extent to which such benefits and risks are unknown; and
    (III) of the option to accept or refuse administration of the product.”

  8. According to the FDA:
    “An investigational drug can also be called an experimental drug and is being studied to see if your disease or medical condition improves while taking it.”

    “Emergency Use IND [Investigational New Drug] allows the FDA to authorize use of an experimental drug in an emergency situation that does not allow time for submission of an IND in accordance with  21CFR , Sec. 312.23 or Sec. 312.20.”

    Further, federal law 21 US Code 360bbb-3 states the “Required Conditions [for emergency use of a product]… include the following:
    (ii) Appropriate conditions designed to ensure that individuals to whom the product is administered are informed-
    (I) that the Secretary has authorized the emergency use of the product;
    (II) of the significant known and potential benefits and risks of such use, and of the extent to which such benefits and risks are unknown; and
    (III) of the option to accept or refuse administration of the product.”

  9. The Public Readiness and Emergency Preparedness Act (PREP Act) authorizes the Secretary of the Department of Health and Human Services (Secretary) to issue a PREP Act declaration. The declaration provides immunity from liability (except for willful misconduct) for claims:
    of loss caused, arising out of, relating to, or resulting from administration or use of countermeasures to diseases, threats and conditions…
    to entities and individuals involved in the development, manufacture, testing, distribution, administration, and use of such countermeasures.”

  10. Under the Civil Rights Act of 1964, an employer is defined as having 15 or more employees and “It shall be an unlawful employment practice for an employer –
    (1) to fail or refuse to hire or to discharge any individual, or otherwise to discriminate against any individual with respect to his compensation, terms, conditions, or privileges of employment, because of such individual’s race, color, religion, sex, or national origin; or
    (2) to limit, segregate, or classify his employees or applicants for employment in any way which would deprive or tend to deprive any individual of employment opportunities or otherwise adversely affect his status as an employee, because of such individual’s race, color, religion, sex, or national origin.”

    Court case: Mission Hospital Agrees to Pay $89,000 To Settle EEOC Religious Discrimination Lawsuit

  11. American Society of Gene + Cell Therapy (ASGCT) President Stephen J. Russell, M.D., Ph.D.: “Approved mRNA Vaccine for COVID-19 is a Milestone for Gene and Cell Therapy…It is the first-ever mRNA vaccine or drug approved by the FDA.

    In mRNA: Fulfilling the Promise of Gene Therapy, an article published in the scientific journal Molecular Therapy, they state: “In vitro–transcribed mRNA (IVT mRNA) is emerging as a new class of drug that has the potential to play a role in gene therapy that once was envisioned for DNA.“

  12. FDA Briefing Document Pfizer-BioNTech COVID-19 Vaccine
    FDA Briefing Document Moderna COVID-19 Vaccine: “As the interim and final analyses have a limited length of follow-up, it is not possible to assess sustained efficacy over a period longer than 2 months.”
    FDA Briefing Document Janssen Ad26.COV2.S Vaccine (Johnson & Johnson)
    How a New Vaccine Was Developed in Record Time in the 1960s: “four years later, in record time, Merck licensed Mumpsvax

  13. Pfizer’s FDA Briefing document:
    page 42 “Female study participants of childbearing potential were screened for pregnancy prior to each vaccination, with a positive test resulting in exclusion or discontinuation from study vaccination.”

    page 49 “There are currently insufficient data to make conclusions about the safety of the vaccine in subpopulations such as children less than 16 years of age, pregnant and lactating individuals, and immunocompromised individuals.”

    Moderna’s FDA Briefing Document:
    page 44 “Study participants of childbearing potential were screened for pregnancy prior to each vaccination, with a positive test resulting in exclusion or discontinuation from study vaccination.”

    page 50 “There are currently insufficient data to make conclusions about the safety of the vaccine in subpopulations such as children less than 18 years of age, pregnant and lactating individuals, and immunocompromised individuals.“

    Janssen’s (Johnson & Johnson) FDA Briefing Document:
    page 52 “Participants were excluded if they were pregnant or planned to become pregnant within 3 months of vaccine administration.”

    page 58 ”There are currently insufficient data to make conclusions about the safety of the vaccine in subpopulations such as children less than 18 years of age, pregnant and lactating individuals and their infants, and immunocompromised individuals.”

    page 50 of Pfizer’s Assessment Report submitted to the European Medicines Agency: “There was an increase (~2x) of pre-implantation loss [miscarriage](9.77%, compared to control 4.09%).”

    page 7 of 2.6.5 SARS-CoV-2 mRNA Vaccine, Pfizer’s animal study submitted to Japanese government: Table 2.6.5.5B. PHARMACOKINETICS: ORGAN DISTRIBUTION CONTINUED

  14. Table 4 Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons
Back To Top css.php